Literature DB >> 19446588

HLA-A01-, -A03-, and -A024-binding nanomeric epitopes in polyomavirus BK large T antigen.

Bala Ramaswami1, Iulia Popescu, Camila Macedo, Diana Metes, Marta Bueno, Adriana Zeevi, Ron Shapiro, Raphael Viscidi, Parmjeet S Randhawa.   

Abstract

Polyomavirus BK (BKV) infections are increasingly recognized. The development of immune-monitoring strategies against BKV requires definition of antigenic epitopes. Bioinformatic algorithms were used to identify 60 BKV large T-antigen (LT-Ag) peptides predicted to bind HLA class I alleles. In vitro peptide binding was used to select a subset of 19 peptides for interferon (IFN)-gamma ELISPOT assays in 13 healthy subjects and 12 kidney transplant recipients. Four A01-, nine A03-, and five A24-binding immunogenic peptides were identified in 1 to 3 (14-67%) tested subjects in each group. BKV epitope sequences were identical to homologous JC virus sequences for 3 of 19 peptides and homologous SV40 sequences for 5 of 19 peptides. Homology modeling localized these epitopes to the helicase, origin of DNA binding, or J domains, respectively. In conclusion, we have identified multiple 9-mer BKV LT-Ag-derived immunogenic epitopes that bind HLA-A01, -A03, or -A24 molecules. Sequence alignments indicate that two epitopes, FLICKGVNK and RYWLFKGPI, are common to BKV, JC virus, and SV40 virus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19446588      PMCID: PMC3086345          DOI: 10.1016/j.humimm.2009.05.003

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  26 in total

Review 1.  Oncogenic transformation by the human polyomaviruses.

Authors:  M J Imperiale
Journal:  Oncogene       Date:  2001-11-26       Impact factor: 9.867

2.  Mechanisms of conformational change for a replicative hexameric helicase of SV40 large tumor antigen.

Authors:  Dahai Gai; Rui Zhao; Dawei Li; Carla V Finkielstein; Xiaojiang S Chen
Journal:  Cell       Date:  2004-10-01       Impact factor: 41.582

3.  Detection of CD8+ T cells sensitized to BK virus large T antigen in healthy volunteers and kidney transplant recipients.

Authors:  Parmjeet S Randhawa; Iulia Popescu; Camila Macedo; Adriana Zeevi; Ron Shapiro; Abhay N Vats; Diana Metes
Journal:  Hum Immunol       Date:  2006-04-07       Impact factor: 2.850

4.  Differential contact of disparate class I/peptide complexes as the basis for epitope cross-recognition by a single T cell receptor.

Authors:  D J Loftus; Y Chen; D G Covell; V H Engelhard; E Appella
Journal:  J Immunol       Date:  1997-04-15       Impact factor: 5.422

5.  Immunoglobulin G, A, and M responses to BK virus in renal transplantation.

Authors:  Parmjeet S Randhawa; Gaurav Gupta; Abhay Vats; Ron Shapiro; Raphael P Viscidi
Journal:  Clin Vaccine Immunol       Date:  2006-09

6.  Cross-reactive CTL recognizing two HLA-A*02-restricted epitopes within the BK virus and JC virus VP1 polypeptides are frequent in immunocompetent individuals.

Authors:  Madeva C Sharma; Wendy Zhou; Joy Martinez; Ludmila Krymskaya; Tumul Srivastava; Wahajul Haq; Don J Diamond; Simon F Lacey
Journal:  Virology       Date:  2006-04-05       Impact factor: 3.616

7.  Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides.

Authors:  Ludmila Krymskaya; Madeva C Sharma; Joy Martinez; Wahajul Haq; Eric C Huang; Ajit P Limaye; Don J Diamond; Simon F Lacey
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy.

Authors:  Yiping Chen; Jennifer Trofe; Jennifer Gordon; Patrick Autissier; E Steve Woodle; Igor J Koralnik
Journal:  J Clin Virol       Date:  2008-03-04       Impact factor: 3.168

9.  Cytotoxic T lymphocyte recognition sequences as markers for distinguishing among tumour antigens encoded by SV40, BKV and JCV.

Authors:  S S Tevethia; L Mylin; R Newmaster; M Epler; J A Lednicky; J S Butel; M J Tevethia
Journal:  Dev Biol Stand       Date:  1998

10.  Characterization of highly frequent epitope-specific CD45RA+/CCR7+/- T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A*0201+ BKV-seropositive donors.

Authors:  Maurizio Provenzano; Laura Bracci; Stephen Wyler; Tvrtko Hudolin; Giovanni Sais; Rainer Gosert; Paul Zajac; Giorgio Palu'; Michael Heberer; Hans H Hirsch; Giulio C Spagnoli
Journal:  J Transl Med       Date:  2006-11-10       Impact factor: 5.531

View more
  7 in total

1.  Polyomavirus JC urinary shedding in kidney and liver transplant recipients associated with reduced creatinine clearance.

Authors:  Shimon Kusne; Regis A Vilchez; Preeti Zanwar; Jorge Quiroz; Marek J Mazur; Raymond L Heilman; David Mulligan; Janet S Butel
Journal:  J Infect Dis       Date:  2012-07-16       Impact factor: 5.226

2.  The polyomavirus BK large T-antigen-derived peptide elicits an HLA-DR promiscuous and polyfunctional CD4+ T-cell response.

Authors:  Bala Ramaswami; Iulia Popescu; Camila Macedo; Chunqing Luo; Ron Shapiro; Diana Metes; Geetha Chalasani; Parmjeet S Randhawa
Journal:  Clin Vaccine Immunol       Date:  2011-03-02

Review 3.  BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.

Authors:  George R Ambalathingal; Ross S Francis; Mark J Smyth; Corey Smith; Rajiv Khanna
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

4.  Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood.

Authors:  Jayasri G Iyer; Olga K Afanasiev; Christopher McClurkan; Kelly Paulson; Kotaro Nagase; Lichen Jing; Joshua O Marshak; Lichun Dong; Joseph Carter; Ivy Lai; Erik Farrar; David Byrd; Denise Galloway; Cassian Yee; David M Koelle; Paul Nghiem
Journal:  Clin Cancer Res       Date:  2011-09-09       Impact factor: 12.531

5.  HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK viremia.

Authors:  Kosuke Masutani; Toshiharu Ninomiya; Parmjeet Randhawa
Journal:  Nephrol Dial Transplant       Date:  2013-09-30       Impact factor: 5.992

Review 6.  Immunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity.

Authors:  Patrizia Comoli; Michela Cioni; Sabrina Basso; Chiara Gagliardone; Leonardo Potenza; Enrico Verrina; Mario Luppi; Marco Zecca; Gian Marco Ghiggeri; Fabrizio Ginevri
Journal:  Clin Dev Immunol       Date:  2013-08-13

7.  Characterization of Immunodominant BK Polyomavirus 9mer Epitope T Cell Responses.

Authors:  M Cioni; C Leboeuf; P Comoli; F Ginevri; H H Hirsch
Journal:  Am J Transplant       Date:  2016-02-17       Impact factor: 8.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.